【普洛药业：拟7500万元-1.5亿元回购股份】普洛药业公告，公司拟7500万元-1.5亿元回购股份，资金来源为自有资金，回购价格不超过22元/股。本次回购股份拟用于股权激励或员工持股计划，若未能在股份回购完成后36个月内实施前述用途，未使用部分将依法履行相关程序后予以注销。

金融界2025-02-19

普洛药业公告，公司拟7500万元-1.5亿元回购股份，资金来源为自有资金，回购价格不超过22元/股。本次回购股份拟用于股权激励或员工持股计划，若未能在股份回购完成后36个月内实施前述用途，未使用部分将依法履行相关程序后予以注销。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2512174211?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-19 18:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2512174211","market":"sh","top_or_hot":-1,"title":"【普洛药业：拟7500万元-1.5亿元回购股份】普洛药业公告，公司拟7500万元-1.5亿元回购股份，资金来源为自有资金，回购价格不超过22元/股。本次回购股份拟用于股权激励或员工持股计划，若未能在股份回购完成后36个月内实施前述用途，未使用部分将依法履行相关程序后予以注销。","media":"金融界","content":"<div>\n<p>普洛药业公告，公司拟7500万元-1.5亿元回购股份，资金来源为自有资金，回购价格不超过22元/股。本次回购股份拟用于股权激励或员工持股计划，若未能在股份回购完成后36个月内实施前述用途，未使用部分将依法履行相关程序后予以注销。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/02/19181348262799.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【普洛药业：拟7500万元-1.5亿元回购股份】普洛药业公告，公司拟7500万元-1.5亿元回购股份，资金来源为自有资金，回购价格不超过22元/股。本次回购股份拟用于股权激励或员工持股计划，若未能在股份回购完成后36个月内实施前述用途，未使用部分将依法履行相关程序后予以注销。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【普洛药业：拟7500万元-1.5亿元回购股份】普洛药业公告，公司拟7500万元-1.5亿元回购股份，资金来源为自有资金，回购价格不超过22元/股。本次回购股份拟用于股权激励或员工持股计划，若未能在股份回购完成后36个月内实施前述用途，未使用部分将依法履行相关程序后予以注销。\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-19 18:13 北京时间&nbsp;&nbsp;&nbsp;<a href=https://24h.jrj.com.cn/2025/02/19181348262799.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>普洛药业公告，公司拟7500万元-1.5亿元回购股份，资金来源为自有资金，回购价格不超过22元/股。本次回购股份拟用于股权激励或员工持股计划，若未能在股份回购完成后36个月内实施前述用途，未使用部分将依法履行相关程序后予以注销。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/02/19181348262799.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0060","symbol_name":"抗癌","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/02/19181348262799.shtml","article_id":"2512174211","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2512174211","pubTimestamp":1739960023,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"普洛药业公告，公司拟7500万元-1.5亿元回购股份，资金来源为自有资金，回购价格不超过22元/股。本次回购股份拟用于股权激励或员工持股计划，若未能在股份回购完成后36个月内实施前述用途，未使用部分将依法履行相关程序后予以注销。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0060":"抗癌","BK0239":"医药制造","000739":"普洛药业","BK0188":"融资融券"},"translate_title":"[Puluo Pharmaceutical: plans to repurchase shares for 75 million to 150 million yuan] Puluo Pharmaceutical announced that the company plans to repurchase shares for 75 million to 150 million yuan. The source of funds is its own funds, and the repurchase price does not exceed 22 yuan/share. The shares repurchased this time are intended to be used for equity incentives or employee stock ownership plans. If the aforementioned purposes cannot be implemented within 36 months after the completion of the share repurchase, the unused part will be cancelled after performing relevant procedures accordin","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000739":1},"content_text":"普洛药业公告，公司拟7500万元-1.5亿元回购股份，资金来源为自有资金，回购价格不超过22元/股。本次回购股份拟用于股权激励或员工持股计划，若未能在股份回购完成后36个月内实施前述用途，未使用部分将依法履行相关程序后予以注销。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"buyback","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2512174211","isCrawlerRequest":true}